摘要
为探讨自拟参白益肠汤口服治疗腹泻型肠易激综合征（D-IBS）的临床疗效，将80例D-IBS患者按就诊顺序随机分为两组，各40例，一组给予自拟参白益肠汤口服治疗（治疗组），一组给予补脾益肠丸口服治疗（对照组）。结果显示，治疗组显效17例，有效19例，无效4例，总有效率为90．0％（36／40）；对照组显效8例，有效22例，无效10例，总有效率为75．0％（30／40）。治疗组总有效率明显高于对照组，P〈0．05。结果表明，自拟参白益肠汤口服治疗D-IBS疗效优于补脾益肠丸口服，疗效肯定。
This study was to investigate the clinical effect of self-designed ShenBai Yichang decoction for treating diarrhea-predominant irritable bowel syndrome（D-IBS）. The 80 patients wlth D-IBS were random- ly divided into treatment group and control group by registration order, 40 cases for each. Treatment group was orally given with self-designed Shenbai Yichang decoction, control group with Bupi Yichang Wan （pill）. As results,in treatment group, excellent response in 17 cases, response in 19, non-response in 4, and total effective rate was 90.0%（36/40）,while in control group,8,22,10 and 75.0% （a0/40）,respectively, thus,the total effective rate of treatment group was significantly highter than that of control group（ P 0.05）. Results show that oral self-designed Shenbai Yichang decoction for treating D-IBS is superior to Bu- pi Yichang Wan（pill）,which has certain effect.
出处
《中国肛肠病杂志》
2012年第12期40-41,共2页
Chinese Journal of Coloproctology
关键词
腹泻型肠易激综合征
参白益肠汤
疗效
Diarrhea-predominant irritable bowel syndrome
Shenbai Yichang decoction
Therapeutic effect
